相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus
Hsin Yeh et al.
PHYTOMEDICINE (2022)
GMI, Ganoderma microsporum protein, suppresses cell mobility and increases temozolomide sensitivity through induction of Slug degradation in glioblastoma multiforme cells
Ai-Jung Tseng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Effective degradation of EGFRL858R+T790M mutant proteins by CRBN-based PROTACs through both proteosome and autophagy/lysosome degradation systems
Xiaojuan Qu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
A small-molecule compound D6 overcomes EGFR-T790M-mediated resistance in non-small cell lung cancer
Xiaolong Tang et al.
COMMUNICATIONS BIOLOGY (2021)
Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders
Meng Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Lysosome-targeting chimaeras for degradation of extracellular proteins
Steven M. Banik et al.
NATURE (2020)
Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth
Nan Yao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
Alessandro Leonetti et al.
BRITISH JOURNAL OF CANCER (2019)
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Ferdinandos Skoulidis et al.
NATURE REVIEWS CANCER (2019)
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
J. -C. Soria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Ganoderma immunomodulatory protein and chidamide down-regulate integrin-related signaling pathway result in migration inhibition and apoptosis induction
Lu Chun-Te et al.
PHYTOMEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Induced protein degradation: an emerging drug discovery paradigm
Ashton C. Lai et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Ping Wee et al.
CANCERS (2017)
FRODOCK 2.0: fast protein-protein docking server
Erney Ramirez-Aportela et al.
BIOINFORMATICS (2016)
Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
Jun Wang et al.
ONCOTARGETS AND THERAPY (2016)
Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
Taebum Lee et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2016)
Immunomodulatory Protein from Ganoderma microsporum Induces Pro-Death Autophagy through Akt-mTOR-p70S6K Pathway Inhibition in Multidrug Resistant Lung Cancer Cells
Ling-Yen Chiu et al.
PLOS ONE (2015)
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
Timothy J. Stuhlmiller et al.
CELL REPORTS (2015)
jvenn: an interactive Venn diagram viewer
Philippe Bardou et al.
BMC BIOINFORMATICS (2014)
Molecular Pathways: Adaptive Kinome Reprogramming in Response to Targeted Inhibition of the BRAF-MEK-ERK Pathway in Cancer
Gary L. Johnson et al.
CLINICAL CANCER RESEARCH (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
Darren A. E. Cross et al.
CANCER DISCOVERY (2014)
The dynamic nature of the kinome
Lee M. Graves et al.
BIOCHEMICAL JOURNAL (2013)
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu et al.
CLINICAL CANCER RESEARCH (2013)
LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both
Nobuyuki Katakami et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Internalization Mechanisms of the Epidermal Growth Factor Receptor after Activation with Different Ligands
Lasse Henriksen et al.
PLOS ONE (2013)
Targeting the ERBB family in cancer: couples therapy
Niall Tebbutt et al.
NATURE REVIEWS CANCER (2013)
Inhibition of lysosome degradation on autophagosome formation and responses to GMI, an immunomodulatory protein from Ganoderma microsporum
I-Lun Hsin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
GMI, an immunomodulatory protein from Ganoderma microsporum, induces autophagy in non-small cell lung cancer cells
I-Lun Hsin et al.
AUTOPHAGY (2011)
Sulindac Metabolites Induce Proteosomal and Lysosomal Degradation of the Epidermal Growth Factor Receptor
Heather A. Pangburn et al.
CANCER PREVENTION RESEARCH (2010)
Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems
Viktor I. Korolchuk et al.
FEBS LETTERS (2010)
Selective autophagy: ubiquitin-mediated recognition and beyond
Claudine Kraft et al.
NATURE CELL BIOLOGY (2010)
A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells
Ching-Hsiung Lin et al.
PROCESS BIOCHEMISTRY (2010)
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
William Pao et al.
NATURE REVIEWS CANCER (2010)
A tale of two Cbls: Interplay of c-Cbl and Cbl-b in epidermal growth factor receptor downregulation
Steven Pennock et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor I (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours
Falm Eskens et al.
BRITISH JOURNAL OF CANCER (2008)
Epidermal growth factor receptor mutations in lung cancer
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2007)
Dynasore, a cell-permeable inhibitor of dynamin
Eric Macia et al.
DEVELOPMENTAL CELL (2006)
Cb1-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits
E Stang et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies
KE Longva et al.
JOURNAL OF CELL BIOLOGY (2002)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
